Anhui Huaren Health Pharmaceutical Co Ltd has reached a 52-week high, driven by strategic acquisitions and favorable government policies, fueling a surge in momentum in the Chinese pharmaceutical sector.

Anhui Huaren Health Pharmaceutical Co Ltd has announced plans to acquire significant stakes in three medical companies, bolstering its presence in the medical retail market through strategic expansion and financial maneuvers.